Nephrosis, Lipoid

• 

  Subject Areas on Research

  • Age of Onset and Disease Course in Biopsy-Proven Minimal Change Disease: An Analysis From the Cure Glomerulonephropathy Network. 
  • CureGN Study Rationale, Design, and Methods: Establishing a Large Prospective Observational Study of Glomerular Disease. 
  • Design of the Nephrotic Syndrome Study Network (NEPTUNE) to evaluate primary glomerular nephropathy by a multidisciplinary approach. 
  • Global glomerulosclerosis with nephrotic syndrome; the clinical importance of age adjustment. 
  • Haemophilus influenzae type b infection after nephrotic syndrome in a previously vaccinated child. 
  • Kidney Biopsy Features Most Predictive of Clinical Outcomes in the Spectrum of Minimal Change Disease and Focal Segmental Glomerulosclerosis. 
  • Management of childhood onset nephrotic syndrome. 
  • Management of idiopathic childhood nephrotic syndrome in sub-Saharan Africa: Ibadan consensus statement. 
  • Pathophysiology and Pathology of Acute Kidney Injury in Patients With COVID-19. 
  • Precision nephrology identified tumor necrosis factor activation variability in minimal change disease and focal segmental glomerulosclerosis. 
  • Prevalence of Cardiovascular Disease Risk Factors in Childhood Glomerular Diseases. 
  • Pulmonary thrombosis in a 10-year-old child with minimal change disease and nephrotic syndrome. A clinical, radiologic, and pathologic correlation with literature review. 
  • Quantification of Glomerular Structural Lesions: Associations With Clinical Outcomes and Transcriptomic Profiles in Nephrotic Syndrome. 
  • Recurrence of nephrotic syndrome following kidney transplantation is associated with initial native kidney biopsy findings. 
  • The predominance of membranoproliferative glomerulonephritis in childhood nephrotic syndrome in Ibadan, Nigeria. 
  • Ultrastructural Characterization of Proteinuric Patients Predicts Clinical Outcomes.